ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
PIMCO Access Income Fund

PIMCO Access Income Fund (PAXS)

16.4693
-0.0107
( -0.06% )
Updated: 14:00:41

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

PAXS News

Official News Only

Discussion

View Full Feed
mackwheaton mackwheaton 3 minutes ago
Good info, thanks proto

I think the $250M shelf might be scaring some, historically offering invite share price drops. I suspect this one will be held for an acquisition or a facility build-out, so it should be more SP neutral (famous last words). The current SP is laughable, but bec
POET
mick mick 4 minutes ago
The latest sign of Intel's struggles and how it got here.

Elliott Management's increased stake in Southwest, and how the activist investor is planning on improving the airline.

Boeing's recent analyst downgrade, and why manufacturing issues might lead to financial ones
Tree Tree 4 minutes ago
Is up the only way to go? :-D
DredLock DredLock 4 minutes ago
Wow! Hate to stay on this topic but like I said my ex walked out on me 3 years ago and the initial pain was UNBEARABLE but since then the peace and stress free life I have now I WISH everybody can experience. I LOVE my life and new gained freedom. I totally understand what you deal with now. I can
IGPK
Cake Eater Cake Eater 4 minutes ago
ANDA (Abbreviated New Drug Application) approvals have several implications for market competition in the pharmaceutical industry:

Increase in Overall ANDA Approvals
The FDA has approved more generic drugs in recent years, particularly during the Generic Drug User Fee Amendment
ELTP
fung_derf fung_derf 4 minutes ago
Considering I'm diversified I'm just dandy. My accounts have been up as late.
Of course, if you took the time to actual look at my posts, I've been advising people to wait to buy SMCI in the low $300's, so not really sure who you think you're schooling? Go back and look at my board as I post
NVDA SMCI
tw0122 tw0122 4 minutes ago
Nice call Glenn
FBLG
Here Today Here Today 4 minutes ago
No it wouldn’t. Posting audited financials showing real revenues in the $millions of dollars will be all it needs to Uplist. As of now, only revenues they have received were off of licensing fees and whatever little bit of online sales they have had. But now with real revenues about to start coming
MILLIONS
ORCA ORCA 4 minutes ago
WHO KNOWS.BUT LIKE I SAID IT IS VERY STRANGE THAT SELLING ALL OF SUDDEN STOPPED.BARBARA HAS NOT SOLD IN MORE THAN 5 WEEKS NOW.WHICH IS THE FIRST TIME IN YEARS.WHAT CHANGED???
VPLM
tw0122 tw0122 4 minutes ago
I smart again lol
FBLG
jammy32 jammy32 5 minutes ago
You’ve added no value
ELTP
vlispxpert vlispxpert 5 minutes ago
last gasps bro, watch & learn son
pos_stock_hoarder pos_stock_hoarder 5 minutes ago
Not that anyone here doesn't know, but I just wanted to tip my hat to Jack Bruce.

And another tip to JPJ of Led Led Zeppelin!
gail gail 5 minutes ago
weeeeee!!!!!! you find all the runners!
BFLY
mick mick 5 minutes ago
The company will wind down the R&D unit that works on light detection and ranging, or lidar, by the end of 2024, affecting about 100 employees. Mobileye employed a total of 3,700 people globally as of Dec. 30, 2023.

Operating expenses for the lidar R&D unit are expected to be about $6
jammy32 jammy32 6 minutes ago
Why do you care ? Do you own anything ? Seriously
ELTP
ptcgolf ptcgolf 6 minutes ago
Speculation to trade - a solid yes, to hold long term absolutely not (throwing your money away). Management clearly cares little about the retail investor, they will end up doing another RS (before the end of the first quarter next year in my opinion). Management will just issue compensatory share
NKLA
Hosai Hosai 6 minutes ago
Interesting though this trial only had 83 on drug and 78 on placebo vs the MRI finding for Anavex which had 165 on drug record a final MRI reading and 100 on placebo.
The effect size seems to be slightly smaller with the dosed group losing 1.2% of grey matter vs dosed group in Blarcamesine t
AVXL
hotdawg hotdawg 6 minutes ago
Nothing on financials till November.
BLEG
stock1ace1 stock1ace1 6 minutes ago
Yes its rolling over busting green and ripping !
jjjjjjjj jjjjjjjj 6 minutes ago
Good work. Good work. Good work. SET SELL HIGH your shares. MJNA is a good company. Best to us longs.
MJNA
justhefax justhefax 7 minutes ago
one issue is the statement in earlier release about all current mgt leaving.

Any new mgt will need to speak to issues prior to reverse such as Kona LLC sale amount among others.





KGKG
TrendTrade2016 TrendTrade2016 7 minutes ago
AND TRAP...WATCH AND LEARN...SCAM!!!
BIEI
SusieQutie SusieQutie 7 minutes ago
It costs money to procure audits and file reports. Money they do not have. They are attempting to obtain more toxic financing, at your expense, in order to get current yet again and continue the scam. “Summer’s Almost Gone.”
TPTW

Your Recent History

Delayed Upgrade Clock